Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 919.50K | 919.50K | 881.00K | 1.53M | 1.35M |
| Depreciation & Amortization | 10.00K | 10.00K | 7.00K | 8.00K | 13.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48M | 1.48M | 1.61M | 2.85M | 3.26M |
| Operating Income | -1.48M | -1.48M | -1.61M | -2.85M | -3.26M |
| Income Before Tax | -1.88M | -1.88M | -1.36M | -1.66M | -24.91M |
| Income Tax Expenses | -2.50K | -2.50K | -- | 2.00K | 1.00K |
| Earnings from Continuing Operations | -1.88M | -1.88M | -1.36M | -1.66M | -24.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 500.00 | 500.00 | 2.00K | 8.00K | 24.00K |
| Net Income | -1.88M | -1.88M | -1.36M | -1.66M | -24.89M |
| EBIT | -1.48M | -1.48M | -1.61M | -2.85M | -3.26M |
| EBITDA | -1.47M | -1.47M | -1.60M | -2.84M | -3.25M |
| EPS Basic | -1.44 | -1.44 | -1.26 | -1.58 | -23.75 |
| Normalized Basic EPS | -0.90 | -0.90 | -0.79 | -0.98 | 1.34 |
| EPS Diluted | -1.44 | -1.44 | -1.26 | -1.58 | -23.75 |
| Normalized Diluted EPS | -0.90 | -0.90 | -0.79 | -0.98 | 1.34 |
| Average Basic Shares Outstanding | 1.30M | 1.30M | 1.08M | 1.05M | 1.05M |
| Average Diluted Shares Outstanding | 1.30M | 1.30M | 1.08M | 1.05M | 1.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |